Azenta Inc
$ 22.69
-0.66%
05 Jun - close price
- Market Cap 1,047,228,000 USD
- Current Price $ 22.69
- High / Low $ 23.01 / 22.14
- Stock P/E N/A
- Book Value 33.73
- EPS -2.41
- Next Earning Report 2026-08-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.07 %
- 52 Week High 41.73
- 52 Week Low 15.93
About
Azenta Inc. is a premier provider of sample management solutions and life science tools, dedicated to enhancing laboratory efficiencies for the biotechnology and pharmaceutical industries. By leveraging innovative automated solutions, comprehensive biorepository services, and advanced storage technologies, the company enables clients to accelerate drug discovery while adhering to stringent regulatory requirements. With a strong emphasis on cutting-edge technology and strategic partnerships, Azenta is well-positioned to seize growth opportunities in the expanding global life sciences market. Its commitment to advancing scientific research through sophisticated products further solidifies its competitive advantage in biobanking and sample management.
Analyst Target Price
$26.20
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-04 | 2025-11-21 | 2025-08-05 | 2025-05-07 | 2025-02-05 | 2024-11-12 | 2024-08-06 | 2024-05-08 | 2024-02-07 | 2023-11-13 | 2023-08-08 |
| Reported EPS | -0.04 | 0.09 | 0.21 | 0.19 | 0.05 | 0.08 | 0.18 | 0.16 | 0.05 | 0.02 | 0.13 | 0.13 |
| Estimated EPS | 0.14 | 0.13 | 0.2 | 0.14 | 0.07 | 0.06 | 0.11 | 0.07 | 0.02 | -0.03 | 0.02 | -0.02 |
| Surprise | -0.18 | -0.04 | 0.01 | 0.05 | -0.02 | 0.02 | 0.07 | 0.09 | 0.03 | 0.05 | 0.11 | 0.15 |
| Surprise Percentage | -128.5714% | -30.7692% | 5% | 35.7143% | -28.5714% | 33.3333% | 63.6364% | 128.5714% | 150% | 166.6667% | 550% | 750% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-04 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.1 |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 | $0.1 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AZTA
2026-06-04 13:40:10
Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (AZTA) on behalf of investors. This investigation follows Azenta's Q2 fiscal 2026 results, which fell short of expectations, revealing "execution gaps" and a "more cautious demand environment," a $149 million goodwill impairment, and a reduced fiscal 2026 outlook. Following this news, Azenta's stock price dropped over 25%.
2026-06-02 20:50:00
This article analyzes Azenta Inc. (AZTA) using AI models to provide trading strategies and a multi-timeframe signal analysis. It highlights strong near and mid-term sentiment but a weak long-term outlook for AZTA, presenting specific entry, target, and stop-loss zones for position, momentum breakout, and risk hedging strategies. The analysis also details support and resistance signals across different time horizons.
2026-05-29 06:39:47
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ:AZTA) following a significant drop in its stock price. This comes after Azenta reported missing second-quarter consensus estimates, announced a $149 million goodwill impairment, and reduced its 2026 financial outlook due to execution shortfalls and a cautious demand environment. The firm is encouraging shareholders to connect to assist with the investigation.
2026-05-28 11:00:00
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (AZTA) after the company missed Q2 2026 earnings estimates, reported a significant goodwill impairment, and lowered its 2026 outlook. Following this news, Azenta's stock price dropped by over 25%. The firm is encouraging shareholders to join the investigation.
2026-05-27 12:40:04
Levi & Korsinsky has announced a securities fraud investigation into Azenta, Inc. (AZTA) after the company slashed its FY 2026 guidance in May 2026, just three months after reaffirming strong organic revenue growth and margin expansion targets. The revision followed a $149 million goodwill impairment and a significant net loss, prompting questions about management's awareness of changing conditions. Shareholders who suffered losses are encouraged to contact Levi & Korsinsky for a free evaluation of their legal rights.
2026-05-26 20:40:38
The Law Offices of Frank R. Cruz is continuing its investigation into Azenta, Inc. (AZTA) for potential violations of federal securities laws after the company missed Q2 2026 financial estimates, reported a significant goodwill impairment, and reduced its 2026 outlook. Following this news, Azenta's stock price dropped by 25.3%, causing losses for investors. Shareholders who lost money are encouraged to contact the law firm to learn more about pursuing a claim.
